Purchase Order 75N91024P00422
Award Date
4/25/24
Potential Completion Date
10/24/24
Potential Value
$19K
Federal Agency
National Cancer Institute
Awardee
Caerus US 1 Inc.
Ultimate Awardee
Not listed
NAICS Category
513210 - Software Publishers
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10119, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $18,000 firm fixed price purchase order to Caerus US 1 Inc. for SOFTWARE. The place of performance is New York, NY. The one year contract starts on July 26, 2023 and ends on July 25, 2024. No set aside designation or subcontractors were identified. The National Cancer Institute is a part of NIH focused on cancer research, so this contract is likely to deliver software products or...
The U.S. Federal Trade Commission (FTC) has awarded a $74,300 firm-fixed-price definitive contract to Caerus US 1 Inc., operating as Citeline, to provide single-user access to Citeline's proprietary "Pink Sheet" and "Generics Bulletin" online services. This contract, which does not have a set-aside designation, will run through December 31, 2027. Caerus US 1 Inc. is a foreign-owned, for-profit organization that specializes in providing pharmaceutical information, drug...
The National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), awarded a $26,870 sole-source purchase order to Caerus US 1 Inc., operating as Citeline, to provide five one-year licenses for its Biomedtracker database and five one-year licenses for the Enhanced Company Deals Upgrade. These software tools will support NCATS' work on intellectual property issues, patent filing, and industry partnerships by providing access to a comprehensive...
This is a $24,468.05 firm fixed-price purchase order awarded by the National Cancer Institute (a civilian agency) to Carahsoft Technology Corp, a provider of information technology products and services to government agencies. The purpose is to procure one man-day of consultation, project management, requirement analysis, business modeling, documentation, installation, configuration, training, or ongoing optimization. The contract has no set-aside designation and an ultimate completion date of...
The Department of Health and Human Services National Institutes of Health National Institute of Environmental Health Sciences (NIEHS) awarded a $222,000.00 Firm Fixed Price Purchase Order contract to Causaly LTD, a for-profit organization based in the United Kingdom. The contract is for the acquisition of a licensing right to use Causaly LTD's proprietary software platform, which utilizes natural language processing and artificial intelligence to discover biomedical knowledge from sources such...
This is a sole source contract awarded by the Federal Trade Commission (FTC) to Caerus US 1 Inc., operating as Citeline, for a license to access Managed Markets Insight & Technology's (MMIT) Formulary Analytics data. The contract has a ceiling value of $247,500.00 and a performance period ending on September 13, 2024. The purpose is to support the FTC's Office of Policy Planning and Bureau of Economics in their research and analysis of pharmaceutical markets. The contract is a Definitive...
This $11,660 firm fixed-price purchase order contract was awarded to Certara USA Inc. by the National Institutes of Health (NIH) Clinical Center, a civilian agency. The contract is for the procurement of software licenses and subscriptions for Certara's proprietary modeling and simulation tools, which enable federal scientists and reviewers to conduct clinical pharmacology, pharmacometric, and regulatory review analyses on data submitted by industry sponsors. Certara USA Inc. is a leading global...
The federal contract award, valued at $10,743.00, was issued by the National Cancer Institute (NCI) to Certara USA Inc., a leading global technology-enabled drug development and drug safety consultancy, for the procurement of software licenses. The contract is a firm-fixed price purchase order with no set-aside designation and an ultimate completion date of August 13, 2025. Certara USA Inc. has received numerous prime contract awards from the NCI, Food and Drug Administration (FDA), and National...
This is a $110,374.86 firm-fixed-price delivery order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Ma Federal, Inc., a small business federal systems integrator and value-added reseller. The contract provides software subscription services and is set aside for small businesses. It is a task order issued under the Chief Information Officer - Commodities and Solutions (CIO-CS) government-wide acquisition contract...
This is a firm fixed price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Clarivate Analytics (Us) LLC, a foreign-owned for-profit organization. The contract provides a software license and maintenance/support program for the METACORE platform. The potential value of the award is $120,355.61, and the period of performance runs through February 23, 2023. No set-aside designation was used for this...